Premium
Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro
Author(s) -
Fromm Michael,
Berdel Wolfgang E.,
Schick Hans D.,
Fink Ulrich,
Pahlke Wulf,
Bicker Uwe,
Reichert Anneliese,
Rastetter Johann
Publication year - 1987
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/bf02535554
Subject(s) - thioether , in vitro , derivative (finance) , lipidology , clinical chemistry , chemistry , pharmacology , stereochemistry , biochemistry , biology , business , finance
Thioether lysophospholipid derivatives (TLP) inhibited the in vitro uptake of [ 3 H]thymidine into blasts of eight leukemias and cells of 12 different solid tumors of human origin. This effect correlated with trypan blue dye exclusion, which was used to assess cell damage. Cytostatic and cytotoxic effects of TLP were dependent on dosage and incubation time. Destruction of leukemic blasts was completed with >5 μg/ml after an incubation of >48 hr, but 10 to 20 μg/ml were necessary in solid tumors. Ester‐linked 2‐lysophosphatidylcholine was ineffective in the same dose range, which points to the requirement of the alkyl moiety in sn ‐1 and a stable sn ‐2 substitution of the molecule for the antineoplastic effect. To assess putative antileukemic selectivity, the cytotoxicity (trypan blue dye exclusion) of TLP was compared in human cell samples of 19 non‐neoplastic bone marrows and 9 leukemias. Results revealed a significantly higher activity of the TLP BM 41.440 in leukemic blasts.